Sientra Announces FDA-Clearance of Novel Portfinder™ Technology
17 mai 2023 08h30 HE
|
Sientra, Inc.
IRVINE, Calif., May 17, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record First Quarter 2023 Operational Results
11 mai 2023 16h02 HE
|
Sientra, Inc.
IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Eleventh consecutive quarter of year-over-year growth, fueled by market outperformance in reconstruction Continued improvement in non-GAAP OPEX,...
Sientra to Report First Quarter 2023 Financial Results on May 11, 2023
01 mai 2023 16h05 HE
|
Sientra, Inc.
IRVINE, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record Fourth Quarter and Full Year Revenues and Expands Total Addressable Market With New Product Launches
30 mars 2023 16h02 HE
|
Sientra, Inc.
Continued 2+ year trend of consecutive record quarterly growth; fastest growing brand in the US breast market Disciplined cash management and enhanced operating leverage for 40% improvement in free...
Sientra to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
20 mars 2023 08h35 HE
|
Sientra, Inc.
IRVINE, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Announces Preliminary Results from Clinical Study and The First Shipment of Viality™ Fat Transfer System
01 mars 2023 08h32 HE
|
Sientra, Inc.
IRVINE, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Announces 1-for-10 Reverse Stock Split
20 janv. 2023 09h25 HE
|
Sientra, Inc.
IRVINE, Calif., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that...
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
29 déc. 2022 16h05 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced...
Sientra Expands Global Footprint With Regulatory Approval to Market Breast Implants in the United Arab Emirates
13 déc. 2022 16h05 HE
|
Sientra, Inc.
IRVINE, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic...
Sientra Reports Record Third Quarter 2022 Financial Results
10 nov. 2022 16h05 HE
|
Sientra, Inc.
SANTA BARBARA, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...